chartexchange

CABA
Cabaletta Bio, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
1.05USD+3.431%(+0.03)4,159,201
Pre-marketNov 18, 2026 9:29:30 AM EST
1.04USD+1.961%(+0.02)
After-hoursNov 18, 2026 4:41:30 PM EST
1.05USD-0.474%(-0.01)
Loading…
Loading…
228.66M
Healthcare
Biotechnology
HQ
Philadelphia, PA, USA
Previous Close
$1.02
Beta
1.90
52-Week High
$4.23 2026-05-06
52-Week Low
$0.98 2026-11-17
SMA 50
$1.80
SMA 200
$2.77
Avg. Vol 10D
4.66M
Avg. Vol 30D
4.82M
Avg. Vol 90D
4.70M
Relative Vol
0.86
215.72M
190.72M
38,369,896
0.4200%
1,700,000
35,869
CABA Profile

cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. the company's lead product candidate is dsg3-caart, which is in phase i clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and hemophilia a with factor viii alloantibodies. its product candidate pipeline also include musk-caart, a preclinical stage product to treat a subset of patients with myasthenia gravis; fviii-caart, a discovery stage product to treat a subset of patients with hemophilia a; and dsg3/1-caart, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. cabaletta bio, inc. has a collaboration with the un

CABA Performance
PeriodPriceDateChangeBeta
1W1.332026-11-12-20.30%8.591
1M1.482026-10-19-28.38%3.106
3M3.102026-08-19-65.81%2.986
6M3.272026-05-19-67.58%2.129
1Y2.242025-11-19-52.68%1.895
2Y2.542024-11-19-58.27%—
5Y11.982021-11-19-91.15%1.495
CABA Stock Summary

Cabaletta Bio, Inc. Common Stock (NASDAQ:CABA) stock price today is $1.06, and today's volume is 4,159,201. CABA is up 3.922% today. The 30 day average volume is 4.82M. CABA market cap is $228.66M with 215.72M shares outstanding.